Efficacy Disease state Safety Previous Next FACE IPF HEAD ON and modify disease progression by slowing lung function decline Adverse Event management brochure 01/06/2022 | Author: Boehringer IngelheimAdverse Event management brochure Document ID: PC-LB-100345 Safety PPF in CTD-ILD: How do we keep patients on treatment with nintedanib? Adverse Event management brochure Prof. Wim Wuyts, Prof. Vincent Cottin, Dr. Anna-Maria Hoffmann-Vold and Prof. Luca Richeldi discussing Risk of Acute Exacerbations in OFEV INBUILD: Adverse event profile RELATED CONTENT Read more 3:50 PPF in CTD-ILD: How do we… PC-AE-102133 ( Fri, 05/08/2026 - 11:16 ) Watch now Opens in new tab Read more 3:12 Prof. Wim Wuyts, Prof.… PC-LB-100402 ( Sun, 08/11/2024 - 00:00 ) Watch now Opens in new tab Read more 2:12 INBUILD: Adverse event profile PC-LB-100404 ( Sun, 08/11/2024 - 00:00 ) Watch now Opens in new tab Home Respiratory Ofev Safety Adverse Event management brochure
Read more 3:50 PPF in CTD-ILD: How do we… PC-AE-102133 ( Fri, 05/08/2026 - 11:16 ) Watch now Opens in new tab
Read more 3:12 Prof. Wim Wuyts, Prof.… PC-LB-100402 ( Sun, 08/11/2024 - 00:00 ) Watch now Opens in new tab
Read more 2:12 INBUILD: Adverse event profile PC-LB-100404 ( Sun, 08/11/2024 - 00:00 ) Watch now Opens in new tab